Lacosamide: A review of preclinical properties

CNS Drug Reviews

Volumn 13, Issue 1, 2007, Pages 21-42

  Beyreuther, Bettina K ^a   Freitag, Joachim ^a   Heers, Cara ^a   Krebsfänger, Niels ^a   Scharfenecker, Ute ^a   Stöhr, Thomas ^a  

^a Schwarz Pharma AG   (Germany)

Author keywords

Analgesics; Anticonvulsants; Epilepsy; Lacosamide; Neuropathic pain

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BICUCULLINE; CARBAMAZEPINE; CHLORIDE CHANNEL BLOCKING AGENT; COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; CYTOCHROME P450; DICLOFENAC; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; HARKOSERIDE; INDOMETACIN; LAMOTRIGINE; MORPHINE; PENTETRAZOLE; PHENYTOIN; PICROTOXIN; PREGABALIN; TIAGABINE; TOPIRAMATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; VOLTAGE GATED SODIUM CHANNEL; XERISTA; ZONEGRAM; ZONISAMIDE;

ANALGESIC ACTIVITY; ANTINOCICEPTION; BINDING AFFINITY; CARCINOGENICITY; CENTRAL NERVOUS SYSTEM; DIABETIC NEPHROPATHY; DISEASE MODEL; DOG; DRUG MECHANISM; DRUG SAFETY; EPILEPSY; EXPERIMENTAL STUDY; FOLLOW UP; GASTROINTESTINAL TRACT; GENITAL SYSTEM; GENOTOXICITY; HUMAN; IN VITRO STUDY; INFLAMMATION; MONOTHERAPY; NEUROPATHIC PAIN; NONHUMAN; PAIN; PROTEIN BINDING; PROTEOMICS; RABBIT; RESPIRATORY SYSTEM; REVIEW; RODENT; SEIZURE; URINARY TRACT;

ACETAMIDES; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EPILEPSY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; PAIN;

EID: 34247855780     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2007.00001.x     Document Type: Review

References (75)

1. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 280 : 1831 1836.
2. Barton ME, Klein BD, Wolf HH, White HS (2001) Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res 47 : 217 227.
3. Bausch SB (2005) Axonal sprouting of GABAergic interneurons in temporal lobe epilepsy. Epilepsy Behav 7 : 390 400.
4. Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD (2005) Efficacy and safety of adjunctive oral lacosamide for the treatment of partial onset seizures in patients with epilepsy. Epilepsia 57 : 30.
5. Beyreuther B, Callizot N, Stohr T (2006) Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy. Eur J Pharmacol 539 : 64 70.
6. Bhalla TN, Tangri KK (1970) The time course of the carrageenan-induced oedema of the paw of the rat. J Pharm Pharmacol 22 : 721.
7. Binder DK (2004) The role of BDNF in epilepsy and other diseases of the mature nervous system. Adv Exp Med Biol 548 : 34 56.
8. Biton V, Rosenfeld W, Whitesides J, Sommerville K (2005) Safety and tolerability of intravenous lacosamide as replacement for oral lacosamide in subjects with partial-onset seizures. Epilepsia 120 : 258.
9. Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, Dzietko M, Pesditschek S, Mai I, Dikranian K, et al. (2002) Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 99 : 15089 15094.
10. Bittigau P, Sifringer M, Genz K, Ikonomidou C (2003) Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci 993 : 103 114.
11. Blackburn-Munro G, Ibsen N, Erichsen HK (2002) A comparison of the anti-nociceptive effects of voltage-activated Na+ channel blockers in the formalin test. Eur J Pharmacol 445 : 231 238.
12. Blair NT, Bean BP (2003) Role of tetrodotoxin-resistant Na+ current slow inactivation in adaptation of action potential firing in small-diameter dorsal root ganglion neurons. J Neurosci 23 : 10338 10350.
13. Borowicz KK, Gasior M, Kleinrok Z, Czuczwar SJ (1997) Influence of isradipine, niguldipine and dantrolene on the anticonvulsive action of conventional antiepileptics in mice. Eur J Pharmacol 323 : 45 51.
14. Boucher TJ, McMahon SB (2001) Neurotrophic factors and neuropathic pain. Curr Opin Pharmacol 1 : 66 72.
15. Boulton AJ (2003) Treatment of symptomatic diabetic neuropathy. Diabetes Metab Res Rev 19 : S16 S21.
16. Brandt C, Heile A, Potschka H, Stöhr T, Löscher W. Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats. Epilepsia 47 : 1803 1809.
17. Bretin S, Rogemond V, Marin P, Maus M, Torrens Y, Honnorat J, Glowinski J, Premont J, Gauchy C (2006) Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit. J Neurochem 98 : 1252 1265.
18. Cavazos JE, Cross DJ (2006) The role of synaptic reorganization in mesial temporal lobe epilepsy. Epilepsy Behav 8 : 483 493.
19. Chevrier P, Vijayaragavan K, Chahine M (2004) Differential modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by the local anesthetic lidocaine. Br J Pharmacol 142 : 576 584.
20. Czech T, Yang JW, Csaszar E, Kappler J, Baumgartner C, Lubec G (2004) Reduction of hippocampal collapsin response mediated protein-2 in patients with mesial temporal lobe epilepsy. Neurochem Res 29 : 2189 2196.
21. D'Amour FE, Smith DL (1941) A method of determining loss of pain sensation. J Pharmacol Exp Ther 72 : 74 79.
22. Danielsson BR, Lansdell K, Patmore L, Tomson T (2003) Phenytoin and phenobarbital inhibit human HERG potassium channels. Epilepsy Res 55 : 147 157.
23. Danielsson BR, Lansdell K, Patmore L, Tomson T (2005) Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents. Epilepsy Res 63 : 17 25.
24. Devor M (2006) Sodium channels and mechanisms of neuropathic pain. J Pain 7 : 3 12.
25. Dubuisson D, Dennis SG (1977) The formalin test: A quantitative study of the analgesic effects of morphine, and brain stem stimulation in rats and cats. Pain 4 : 161 174.
26. Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A (2001) Lamotrigine reduces painful diabetic neuropathy: A randomized, controlled study. Neurology 57 : 505 509.
27. Errington AC, Coyne L, Stohr T, Selve N, Lees G (2006) Seeking a mechanism of action for the novel anticonvulsant lacosamide. Neuropharmacology 50 : 1016 1029.
28. Fleidervish IA, Friedman A, Gutnick MJ (1996) Slow inactivation of Na+ current and slow cumulative spike adaptation in mouse and guinea-pig neocortical neurones in slices. J Physiol 493 : 83 97. Erratum in: J Physiol 494:907.
29. Field MJ, Oles RJ, Lewis AS, McCleary S, Hughes J, Singh L (1997) Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol 121 : 1513 1522.
30. Gimbel JS, Richards P, Portenoy RK (2003) Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial. Neurology 60 : 927 934.
31. Glier C, Dzietko M, Bittigau P, Jarosz B, Korobowicz E, Ikonomidou C (2004) Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol 187 : 403 409.
32. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S (2005) Duloxetine vs placebo in patients with painful diabetic neuropathy. Pain 116 : 109 118.
33. Hao J, Stöhr T, Selve N, Wiesenfeld-Hallin Z, Xu X (2006) Lacosamide, a new anti-epileptic, alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury. Eur J Pharmacol 553 : 135 140.
34. Herman ST, Pedley TA (1998) New options for the treatment of epilepsy. JAMA 280 : 693 694.
35. Hidvégi T, Bretschneider M, Bongardt S, Koch B (2006) Lacosamide in subjects with painful distal diabetic neuropathy: Results of a multi-center, randomized, double-blind, placebo-controlled, parallel-group trial. J Pain 7 : 45.
36. Hönack D, Löscher W (1995) Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs. Epilepsia 36 : 763 771.
37. Honerjäger P (1986) The contribution of Na channel block to the negative inotropic effect of antiarrhythmic drugs. Basic Res Cardiol 81 : 33 37.
38. Honerjäger P, Loibl E, Steidl I, Schonsteiner G, Ulm K (1986) Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockade. Naunyn Schmiedeberg's Arch Pharmacol 332 : 184 195.
39. Hurley RW, Chatterjea D, Rose Feng M, Taylor CP, Hammond DL (2002) Gabapentin and pregabalin can interact synergistically with naproxen to produce antihyperalgesia. Anesthesiology 97 : 1263 1273.
40. Kobayashi M, Wen X, Buckmaster PS (2003) Reduced inhibition and increased output of layer II neurons in the medial entorhinal cortex in a model of temporal lobe epilepsy. J Neurosci 23 : 8471 8479.
41. Löscher W (1999) Animal models of epilepsy and epileptic seizures. In : Eadie MJ, Vajda FJ, editors. Antiepileptic drugs, pharmacology, and therapeutics, handbook of experimental pharmacology. Berlin, Germany, Springer Verlag, pp. 19 62.
42. Luszczki JJ, Andres MM, Czuczwar P, Cioczek-Czuczwar A, Wojcik-Cwikla J, Ratnaraj N, Patsalos PN, Czczwar SJ (2005) Levetiracetam selectively potentiates the acute neurotoxic effects of topiramate and carbamazepine in the rotarod test in mice. Eur Neuropsychopharmacol 15 : 609 616.
43. Manthey D, Asimiadou S, Stefovska V, Kaindl AM, Fassbender J, Ikonomidou C, Bittigau P (2005) Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol 193 : 497 503.
44. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R (1992) Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326 : 1250 1256.
45. McCleane G, Koch B, Rauschkolb C (2003) Does lacosamide have an analgesic effect in human neuropathic pain? An open label study. Neurosci Lett 352 : 117 120.
46. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA (1996) A systematic review of antidepressants in neuropathic pain. Pain 68 : 217 227.
47. Melzack R, Coderre TJ, Katz J, Vaccarino AL (2001) Central neuroplasticity and pathological pain. Ann N Y Acad Sci 933 : 157 174.
48. Mestre M, Djellas Y, Carriot T, Cavero I (2000) Frequency-independent blockade of cardiac Na+ channels by riluzole: Comparison with established anticonvulsants and class I anti-arrhythmics. Fundam Clin Pharmacol 14 : 107 117.
49. Mickus T, Jung H, Spruston N (1999) Properties of slow, cumulative sodium channel inactivation in rat hippocampal CA1 pyramidal neurons. Biophys J 76 : 846 860.
50. Morrow TJ, Agacinski S, Polen D, Swindell MK, Selve N (2001) Antinociceptive properties of the anticonvulsant SPM 927 (harkoseride) in rat Soc Neurosci abstract no. 508.16.2001.
51. Nagakura Y, Okada M, Kohara A, Kiso T, Toya T, Iwai A, Wanibuchi F, Yamaguchi T (2003) Allodynia and hyperalgesia in adjuvant-induced arthritic rats: Time course of progression and efficacy of analgesics. J Pharmacol Exp Ther 306 : 490 497.
52. Ness TJ, Gebhart GF (1986) Centrifugal modulation of the rat tail flick reflex evoked by graded noxious heating of the tail. Brain Res 386 : 41 52.
53. Patel S, Naeem S, Kesingland A, Froestl W, Capogna M, Urban L, Fox A (2001) The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain 90 : 217 226.
54. Perucca E (1996) Established antiepileptic drugs. Baillière's Clin Neurol 5 : 693 722.
55. Perucca E, Gram L, Avanzini G, Dulac O (1998) Antiepileptic drugs as a cause of worsening seizures. Epilepsia 39 : 5 17.
56. Pezet S, McMahon SB (2006) Neurotrophins: Mediators and modulators of pain. Annu Rev Neurosci 29 : 507 538.
57. Regnier J (1929) Méthode de mesure des anesthesiques locaux. Thèse Doct. Méd., St Dizier, France.
58. Rogawski MA, Löscher W (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5 : 553 564.
59. Rosenfeld W, Biton V, Mameniskiene R, Vaiciene N, Whitesides J, Shiltmeyer B, Sommerville K 2005) Pharmacokinetics and safety of intravenous lacosamide administered as replacement for adjunctive oral lacosamide in patients with partial-onset seizures. Epilepsia 184 : 2.278.
60. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U (2004) Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial. Pain 110 : 628 638.
61. Sander JW (1998) New drugs for epilepsy. Curr Opin Neurol 11 : 141 148.
62. Sazgar M, Bourgeois BF (2005) Aggravation of epilepsy by antiepileptic drugs. Pediatr Neurol 33 : 227 234.
63. Sindrup SH, Jensen TS (1999) Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83 : 389 400.
64. Singh L, Field MJ, Ferris P, Hunter JC, Oles RJ, Williams RG, Woodruff GN (1996) The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology 127 : 1 9.
65. Shaibani A, Kenney P, Simpson J, Bongardt S (2006) Lacosamide in subjects with painful distal diabetic neuropathy: Results of a multi-center, open-label, follow-on trial. J Pain 7 : 43.
66. Stohr T, Krause E, Selve N (2006) Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain. Eur J Pain 10 : 241 249.
67. Stohr T, Kupferberg HJ, Stables JP, Choi D, Harris RH, Kohn H, Walton N, White S (2007) Lacosamide, a novel anticonvulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy. Epilepsy Res Submitted.
68. Swinyard EA, Brown WC, Goodman LS (1952) Comparative assays of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther 106 : 319 330.
69. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K (1992) The formalin test: An evaluation of the method. Pain 51 : 5 17.
70. Tongiorgi E, Domenici L, Simonato M (2006) What is the biological significance of BDNF mRNA targeting in the dendrites? Clues from epilepsy and cortical development. Mol Neurobiol. 33 : 17 32.
71. Villetti G, Bergamaschi M, Bassani F, Bolzoni PT, Maiorino M, Pietra C, Rondelli I, Chamiot-Clerc P, Simonato M, Barbieri M (2003) Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)- glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 306 : 804 814.
72. Webster R, Leishman D, Walker D (2002) Towards a drug concentration effect relationship for QT prolongation and torsades de pointes. Curr Opin Drug Discov Devel 5 : 116 126.
73. Wymer J, Garrison C, Simpson J, Koch B (2006) A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of lacosamide in subjects with painful distal diabetic neuropathy. Neurology 66 : A202.
74. Yamaguchi T (2003) Allodynia and hyperalgesia in adjuvant-induced arthritic rats: Time course of progression and efficacy of analgesics. J Pharmacol Exp Ther 306 : 490 497.
75. Yoshimura T, Kawano Y, Arimura N, Kawabata S, Kikuchi A, Kaibuchi K (2005) GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120 : 137 149.